2026 International Spring Forum
April 15, 2026 | 12:00 PM EST
- Home
- Clinical Resources Search
- PQI in Action: Oral Formulation of Decitabine and Cedazuridine (Inqovi®) for Hematological Malignancies
Oral Formulation of Decitabine and Cedazuridine (Inqovi®) for Hematological Malignancies
About this PQI in Action
This PQI in Action is a follow up to the Oral Formulation of Decitabine and Cedazuridine (Inqovi®) for Hematological Malignancies PQIand explores how the medically integrated teams at Hematology-Oncology Associates of Central New York (HOACNY) and the McFarland Clinic collaborate and utilize the information found in the PQI as part of their daily practice. This article will discuss how utilizing the Oral Formulation of Decitabine and Cedazuridine (Inqovi®) for Hematological Malignancies PQI elevates patient care.
More About This PQI in Action
Find a PQIPQI in Action
PQI in Action: Oral Formulation of Decitabine and Cedazuridine (Inqovi®) for Hematological Malignancies
Last Updated: 01/11/2024 12:00 am
PQI
PQI: Oral Formulation of Decitabine and Cedazuridine (Inqovi®) for Hematological Malignancies
Last Updated: 14/11/2023 12:00 am